US 11578135
Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof
granted A61KA61K39/3955A61K47/6817
Quick answer
US patent 11578135 (Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K39/3955, A61K47/6817, A61K47/6879, A61P